Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease.
Two hundred patients with liver disease were re-studied after six to eight years. The initial routine diagnosis (mainly based on morphological criteria) was confirmed in almost 80% of cases of chronic liver disease. In chronic active hepatitis, agreement was found in 86%. An alternative classification based on cluster analysis of clinical chemical results from the first admission was also to a great extent confirmed by the follow-up study. Discriminant analysis of clinical chemical data correctly allocated 94% of patients with alcoholic cirrhosis (who had low haptoglobin and albumin) into groups with different prognosis. Clinical chemical results differed between verified and non-verified cases of primary biliary cirrhosis. By retrospective examination , we found that 15 of 16 patients with this disease or chronic active hepatitis who were initially misclassified by biopsy findings could be correctly diagnosed by discriminant analysis of clinical chemical results.
D001706:Biopsy; D001779:Blood Coagulation Factors / Q000032:analysis; D002570:Ceruloplasmin / Q000032:analysis; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D006505:Hepatitis / Q000175:diagnosis; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008104:Liver Cirrhosis, Alcoholic / Q000175:diagnosis; D008105:Liver Cirrhosis, Biliary / Q000175:diagnosis; D008107:Liver Diseases / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D009664:Norway; D011336:Probability; D011379:Prognosis; D012189:Retrospective Studies
D001779:Blood Coagulation Factors; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D002570:Ceruloplasmin